Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

1.

Adverse cardiovascular events temporally associated with ma huang, an herbal source of ephedrine.

Samenuk D, Link MS, Homoud MK, Contreras R, Theoharides TC, Wang PJ, Estes NA 3rd.

Mayo Clin Proc. 2002 Jan;77(1):12-6. Erratum in: Mayo Clin Proc. 2003 Aug;78(8):1055. Theohardes Theoharis C [corrected to Theoharides Theoharis C].

PMID:
11795249
[PubMed - indexed for MEDLINE]
2.

[Ma Huang, from dietary supplement to abuse].

Arditti J, Bourdon JH, Spadari M, de Haro L, Richard N, Valli M.

Acta Clin Belg Suppl. 2002;(1):34-6. Review. French.

PMID:
11974441
[PubMed - indexed for MEDLINE]
3.

Acute hepatitis associated with the use of a Chinese herbal product, ma-huang.

Nadir A, Agrawal S, King PD, Marshall JB.

Am J Gastroenterol. 1996 Jul;91(7):1436-8. Review.

PMID:
8678010
[PubMed - indexed for MEDLINE]
4.

Cardiovascular effects of ephedra alkaloids: a comprehensive review.

Andraws R, Chawla P, Brown DL.

Prog Cardiovasc Dis. 2005 Jan-Feb;47(4):217-25. Review.

PMID:
15991150
[PubMed - indexed for MEDLINE]
5.

Ephedra-containing dietary supplements in the US versus ephedra as a Chinese medicine.

Mehendale SR, Bauer BA, Yuan CS.

Am J Chin Med. 2004;32(1):1-10. Review.

PMID:
15154280
[PubMed - indexed for MEDLINE]
6.

Do prescription stimulants increase the risk of adverse cardiovascular events?: A systematic review.

Westover AN, Halm EA.

BMC Cardiovasc Disord. 2012 Jun 9;12:41. doi: 10.1186/1471-2261-12-41. Review.

PMID:
22682429
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Seizures reported in association with use of dietary supplements.

Haller CA, Meier KH, Olson KR.

Clin Toxicol (Phila). 2005;43(1):23-30. Review.

PMID:
15732443
[PubMed - indexed for MEDLINE]
8.

Safety concerns regarding ephedrine-type alkaloid-containing dietary supplements.

Miller SC.

Mil Med. 2004 Feb;169(2):87-93. Review.

PMID:
15040625
[PubMed - indexed for MEDLINE]
9.

Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis.

Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR.

BMJ. 2011 Apr 19;342:d2040. doi: 10.1136/bmj.d2040. Review.

PMID:
21505219
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

The emerging cardiovascular risk profile for nonsteroidal anti-inflammatory drugs: implications for clinical nurse specialist practice.

O'Malley P.

Clin Nurse Spec. 2006 Nov-Dec;20(6):277-65. Review. No abstract available.

PMID:
17149016
[PubMed - indexed for MEDLINE]
11.

Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies.

Armstrong EJ, Harskamp CT, Armstrong AW.

J Am Heart Assoc. 2013 Apr 4;2(2):e000062. doi: 10.1161/JAHA.113.000062. Review.

PMID:
23557749
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options.

Phillips K, Luk A, Soor GS, Abraham JR, Leong S, Butany J.

Am J Cardiovasc Drugs. 2009;9(3):177-96. doi: 10.2165/00129784-200909030-00005. Review.

PMID:
19463023
[PubMed - indexed for MEDLINE]
13.

Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis.

Bolland MJ, Avenell A, Baron JA, Grey A, MacLennan GS, Gamble GD, Reid IR.

BMJ. 2010 Jul 29;341:c3691. doi: 10.1136/bmj.c3691. Review.

PMID:
20671013
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis.

Prochaska JJ, Hilton JF.

BMJ. 2012 May 4;344:e2856. doi: 10.1136/bmj.e2856. Review.

PMID:
22563098
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder.

Martinez-Raga J, Knecht C, Szerman N, Martinez MI.

CNS Drugs. 2013 Jan;27(1):15-30. doi: 10.1007/s40263-012-0019-9. Review.

PMID:
23160939
[PubMed - indexed for MEDLINE]
16.

Addressing the potential risks associated with ephedra use: a review of recent efforts.

Schulman S.

Public Health Rep. 2003 Nov-Dec;118(6):487-92. Review.

PMID:
14563905
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature.

Thomas JE, Munir JA, McIntyre PZ, Ferguson MA.

Tex Heart Inst J. 2009;36(6):586-90. Review.

PMID:
20069086
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Cardiovascular and neurological causes of sudden death after ischaemic stroke.

Sörös P, Hachinski V.

Lancet Neurol. 2012 Feb;11(2):179-88. doi: 10.1016/S1474-4422(11)70291-5. Review.

PMID:
22265213
[PubMed - indexed for MEDLINE]
19.

Cardiovascular toxicities of performance-enhancing substances in sports.

Dhar R, Stout CW, Link MS, Homoud MK, Weinstock J, Estes NA 3rd.

Mayo Clin Proc. 2005 Oct;80(10):1307-15. Review. Erratum in: Mayo Clin Proc. 2006 Jan;81(1):133.

PMID:
16212144
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk